Type I Glanzmann's thrombasthenia in a Great Pyrenees dog.
An 8-month-old female Great Pyrenees dog with chronic epistaxis and a history of gingival bleeding during shedding of deciduous teeth was evaluated for platelet function. Platelet morphology was normal at both the light and electron microscopic level. Platelet number and mean platelet volume were also normal. Platelet aggregation responses to adenosine diphosphate, collagen, platelet activating factor, and thrombin were markedly reduced, although shape change responses were normal. Clot retraction was markedly impaired. Monoclonal antibody (MoAb) Y2/51, a murine anti-human platelet beta 3 antibody that cross-reacts with canine platelet beta 3, and MoAb 5G11, a murine anti-dog platelet alpha IIb beta 3 antibody, bound minimally to affected dog platelets, as demonstrated by flow cytometry. Binding of MoAb Y2/51 was not detectable by immunoblot. MoAb CAP1, a murine anti-dog fibrinogen receptor-induced binding site antibody, failed to bind to affected dog platelets, as demonstrated by flow cytometry. A reduction in glycoproteins alpha IIb and beta 3 was demonstrated by two-dimensional protein electrophoresis. This is the first reported case of type I Glanzmann's thrombasthenia in the dog that closely resembles the clinical syndrome and the platelet morphology described in type I Glanzmann's thrombasthenia of human beings.
Boudreaux
M K
MK
Department of Pathobiology, Auburn University, AL, USA.
Kvam
K
K
Dillon
A R
AR
Bourne
C
C
Scott
M
M
Schwartz
K A
KA
Toivio-Kinnucan
M
M
D000818:Animals; D003018:Clot Retraction; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005434:Flow Cytometry; D015151:Immunoblotting; D015592:Immunoradiometric Assay; D010974:Platelet Aggregation; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000032:analysis; D013915:Thrombasthenia / Q000473:pathology* / Q000662:veterinary*
D019039:Platelet Glycoprotein GPIIb-IIIa Complex